Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease
- Todd A. Lee, PharmD, PhD;
- A. Simon Pickard, PhD;
- David H. Au, MD, MS;
- Brian Bartle, MPH; and
- Kevin B. Weiss, MD, MPH, MS
- From the Hines Veterans Affairs Hospital, Hines, Illinois; Northwestern University Feinberg School of Medicine, Chicago, Illinois; University of Illinois at Chicago, Chicago, Illinois; Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington; and the American Board of Medical Specialties, Evanston, Illinois.
-
Figure 2. Risk for mortality associated with respiratory medications in the sensitivity analyses for each study end point.
Bars indicate 95% CIs. CHF = chronic heart failure; ICS = inhaled corticosteroid; IPRA = ipratropium; LABA = long-acting β-agonist; SABA = short-acting β-agonist; THEO = theophylline.
RSS Feeds











